During the past decade, Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 40 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 26 clinical trials were completed. i.e. 83.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet" #1 sponsor was "Hoffmann-La Roche" with 19 trials, followed by "Pfizer" with 12 trials sponsored, "Amgen" with 4 trials sponsored, "Incyte Corporation" with 4 trials sponsored and "Merck Sharp & Dohme LLC" with 4 trials sponsored. Other sponsors include 39 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet" #1 collaborator was "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet" are "Carcinoma, Non-Small-Cell Lung" (7 trials), "Breast Cancer" (6 trials), "Non-Small Cell Lung Cancer" (5 trials), "Gastric Cancer" (3 trials) and "Gastroparesis" (3 trials). Many other conditions were trialed in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet" in a lesser frequency.

Most popular intervention types in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet" are "Drug" (82 trials), "Biological" (9 trials), "Other" (6 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Carboplatin" (13 trials), "Gemcitabine" (13 trials), "Cisplatin" (8 trials) and "Paclitaxel" (8 trials). Other intervention names were less common.

The vast majority of trials in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet" are 77 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet". undefined are not yet recruiting, 15 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, 3 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".